201
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Prospective Study Comparing Quantitative Self-Monitoring Metamorphopsia Measurement Tools in Myopic Choroidal Neovascularization (mCNV)

, , , & ORCID Icon
Pages 1347-1355 | Received 03 Nov 2022, Accepted 28 Apr 2023, Published online: 09 May 2023

References

  • Simunovic MP. Metamorphopsia And Its Quantification. Retina. 2015;35(7):1285–1291. doi:10.1097/IAE.0000000000000581
  • Holden BA, Fricke TR, Wilson DA, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036–1042. doi:10.1016/j.ophtha.2016.01.006
  • Haarman AEG, Enthoven CA, Tideman JWL, et al. The complications of myopia: a review and meta-analysis. Invest Ophthalmol Vis Sci. 2020;61(4):49. doi:10.1167/iovs.61.4.49
  • Keane PA, Liakopoulos S, Chang KT, et al. Comparison of the optical coherence tomographic features of choroidal neovascular membranes in pathological myopia versus age-related macular degeneration, using quantitative subanalysis. Br J Ophthalmol. 2008;92(8):1081–1085. doi:10.1136/bjo.2008.138891
  • Cheng Y, Li Y, Huang X, Qu Y. Application of optical coherence tomography angiography to assess anti-vascular endothelial growth factor therapy in myopic choroidal neovascularization. Retina. 2019;39(4):712–718. doi:10.1097/IAE.0000000000002005
  • Cheung CMG, Arnold JJ, Holz FG, et al. Myopic choroidal neovascularization: review, guidance, and consensus statement on management. Ophthalmology. 2017;124(11):1690–1711. doi:10.1016/j.ophtha.2017.04.028
  • Wolf S, Balciuniene VJ, Laganovska G, et al. RADIANCE: a randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia. Ophthalmology. 2014;121(3):682–92.e2. doi:10.1016/j.ophtha.2013.10.023
  • Ikuno Y, Ohno-Matsui K, Wong TY, et al. Intravitreal aflibercept injection in patients with myopic choroidal neovascularization: the MYRROR study. Ophthalmology. 2015;122(6):1220–1227. doi:10.1016/j.ophtha.2015.01.025
  • Guichard MM, Peters G, Tuerksever C, et al. Outcome predictors of SD-OCT-driven intravitreal ranibizumab in choroidal neovascularization due to myopia. Ophthalmologica. 2020;243(2):154–162. doi:10.1159/000501040
  • Karasu B, Celebi ARC. The efficacy of different anti-vascular endothelial growth factor agents and prognostic biomarkers in monitoring of the treatment for myopic choroidal neovascularization. Int Ophthalmol. 2022;42(9):2729–2740. doi:10.1007/s10792-022-02261-1
  • Faes L, Islam M, Bachmann LM, et al. Correction: false alarms and the positive predictive value of smartphone-based hyperacuity home monitoring for the progression of macular disease: a prospective cohort study. Eye. 2021. doi:10.1038/s41433-021-01512-2
  • Schmid MK, Thiel MA, Lienhard K, et al. Reliability and diagnostic performance of a novel mobile app for hyperacuity self-monitoring in patients with age-related macular degeneration. Eye. 2019;33(10):1584–1589. doi:10.1038/s41433-019-0455-6
  • Claessens D, Schuster AK, Krüger RV, et al. Test-retest-reliability of computer-based metamorphopsia measurement in macular diseases. Test-retest-reliabilität der computergestützten metamorphopsiemessung bei makulaerkrankungen. Klin Monbl Augenheilkd. 2021;238(6):703–710. doi:10.1055/a-1252-2910
  • Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15(2):155–163. doi:10.1016/j.jcm.2016.02.012
  • Hanumunthadu D, Lescrauwaet B, Jaffe M, et al. Clinical update on metamorphopsia: epidemiology, diagnosis and Imaging. Curr Eye Res. 2021;46(12):1777–1791. doi:10.1080/02713683.2021.1912779
  • Claessens D, Schuster AK. Correlation of quantitative metamorphopsia measurement and central retinal thickness in diabetic macular edema and age-related exsudative macular degeneration. Klin Monbl Augenheilkd. 2019;236(7):877–884. doi:10.1055/s-0043-125080
  • Islam M, Sansome S, Das R, et al. Smartphone-based remote monitoring of vision in macular disease enables early detection of worsening pathology and need for intravitreal therapy. BMJ Health Care Inform. 2021;28(1):e100310. doi:10.1136/bmjhci-2020-100310
  • McBride CM, Morrissey EC, Molloy GJ. Patients’ experiences of using smartphone apps to support self-management and improve medication adherence in hypertension: qualitative study. JMIR Mhealth Uhealth. 2020;8(10):e17470. doi:10.2196/17470
  • Teo KYC, Bachmann LM, Sim D, et al. Patterns and characteristics of a clinical implementation of a self-monitoring program for retina diseases during the COVID-19 pandemic. Ophthalmol Retina. 2021;S2468(21):55.
  • Claessens D, Ichhpujani P, Singh RB. MacuFix® versus Amsler grid for metamorphopsia categorization for macular diseases. Int Ophthalmol. 2021;22:1–10.